Skip to content
healthcare.dev

TIGLUTIK

NDC 11797-210, Riluzole, suspension, from Italfarmaco SPA.

Product NDC
11797-210
Status
Listed
Labeler
Italfarmaco SPA
Dosage form
SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA209080
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/11797-210 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RILUZOLE50 mg/10mL

Pharmacologic classes

Benzothiazole [EPC]; Benzothiazoles [CS]

Package NDCNDC-11Package
11797-210-01117970210012 BOTTLE, PLASTIC in 1 CARTON (11797-210-01) / 300 mL in 1 BOTTLE, PLASTIC

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/20b7165a-eb4d-42a0-b2d8-16eff90a214e

Use it

Look up 11797-210 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/11797-210 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 11797-210. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.